Literature DB >> 36267749

Sheng-Xue-Xiao-Ban Capsule-induced ischemic colitis and pulmonary embolism in an idiopathic thrombocytopenic purpura patient: a rare case report.

Sisi Zhou1, Quan Shi1, Yanfeng Zheng1, Yihan Zhuang1, Yiting Lin1, Zeyu Huang1, Jing Yu1.   

Abstract

Background: Sheng-Xue-Xiao-Ban Capsule (SXXBC), as a classic Chinese traditional medicine comprised of natural indigo, cortex moutan, forsythia, herba agrimoniae, and licorice, exhibits a heat-clearing and detoxicating function, hemostasis, and stasis dissipation, which is widely applied to treat idiopathic thrombocytopenic purpura (ITP). However, report on ischemic colitis and pulmonary embolism induced by SXXBC therapy is never disclosed. We report the case of an ITP patient who received SXXBC for ascending platelets that then induced ischemic colitis and pulmonary embolism. Case Description: A 74-year-old female patient was admitted in June 2021 due to "bleeding in stool for 1 day," she was then re-admitted in July 2021 due to "repeated bleeding in stool for 2 days". Abdominal computed tomography (CT), colonoscopy, and a pathological examination suggested ischemic colitis according to the American College of Gastroenterology (ACG) clinical guidelines. Pulmonary artery CT angiography suggested pulmonary embolism reflected by multiple filling defects, and the patient presented with shortness of breath. It was noted that the patient had started taken SXXBC for ascending platelets 2 months before the onset of hematochezia. After the diagnosis of hematochezia was made, the patient received phenethylamine and carbazochrome for hemostasis, mesalazine enteric-coated tablets for anti-inflammation, and SXXBC was stopped. The hematochezia then ceased, and the ischemic colitis was attenuated. Afterwards, low-molecular-weight heparin was administered, followed by a 3-week treatment of rivaroxaban anticoagulant, which was taken orally after discharge. The pulmonary embolism was then obviously ameliorated. After excluding other causes, the patient was diagnosed with SXXBC-induced ischemic colitis complicated by pulmonary embolism. After conducting research, we came to the view that natural indigo, which is the main component of SXXBC, contributed to the patient's illness. Conclusions: Ischemic colitis complicated with pulmonary embolism are rare; however, close attention such as regular abdominal CT test needs to be paid and preventive steps such as anti-coagulant treatment could to be taken (if symptoms occur) when treating patients with SXXBC. 2022 Annals of Translational Medicine. All rights reserved.

Entities:  

Keywords:  Sheng-Xue-Xiao-Ban Capsule (SXXBC); case report; idiopathic thrombocytopenic purpura (ITP); ischemic colitis; pulmonary embolism

Year:  2022        PMID: 36267749      PMCID: PMC9577723          DOI: 10.21037/atm-22-3951

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  14 in total

1.  [Preliminary exploration on the colonic inflammatory change induced by compound indigo pill and its possible mechanism].

Authors:  Li-ping Duan; Wei-hong Yang; Yu-min Lu; Xiuyun Dong; Zhu Jin; Sanren Lin
Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi       Date:  2004-07

2.  ACG clinical guideline: epidemiology, risk factors, patterns of presentation, diagnosis, and management of colon ischemia (CI).

Authors:  Lawrence J Brandt; Paul Feuerstadt; George F Longstreth; Scott J Boley
Journal:  Am J Gastroenterol       Date:  2014-12-23       Impact factor: 10.864

3.  Ischemic Colitis.

Authors:  Bilal Azam; Mohan Kumar; Kundan Mishra; Deba Prasad Dhibar
Journal:  J Emerg Med       Date:  2019-03-06       Impact factor: 1.484

Review 4.  Insights into the pathogenesis of catastrophic antiphospholipid syndrome. A case report of relapsing catastrophic antiphospholipid syndrome and review of the literature on ischemic colitis.

Authors:  Amelia Ruffatti; Antonia Calligaro; Carmelo S Lacognata; Anna D'Odorico; Anna Colpo; Fabrizio Cardin; Fiorella Calabrese
Journal:  Clin Rheumatol       Date:  2019-12-18       Impact factor: 2.980

5.  [Effect of Indirubin and Sheng-Xue-Xiao-Ban Capsule (SXXBC) on Promoting Peripheral Platelet in ITP Model Mice].

Authors:  Feng-Qin Shi; Peng Lyu; Hao He; Li-Zhen Han; Chang-Yu Liu; Hong-Chao Yan; Chong Wang; Xin-Yi Chen
Journal:  Zhongguo Shi Yan Xue Ye Xue Za Zhi       Date:  2020-12

6.  Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older.

Authors:  Marie Joelle Jabagi; Jérémie Botton; Marion Bertrand; Alain Weill; Paddy Farrington; Mahmoud Zureik; Rosemary Dray-Spira
Journal:  JAMA       Date:  2022-01-04       Impact factor: 56.272

7.  Clinical presentations and outcomes in pulmonary embolism patients with cancer.

Authors:  Cherry Au; Ena Gupta; Phue Khaing; Joseph Dibello; Todd Chengsupanimit; Edith P Mitchell; Frances Mae West; Michael Baram; Bharat K Awsare; Gregory C Kane
Journal:  J Thromb Thrombolysis       Date:  2020-10-12       Impact factor: 2.300

8.  NSAID-induced ischemic colitis.

Authors:  Olivia Sierra Gabarda; María Espinosa Pérez; Diego Casas Deza; Luis Javier Lamuela Calvo; Mónica Llorente Barrio; Rosario María Monzón Báez; Eva Sierra Moros; Javier Alcedo González
Journal:  Rev Esp Enferm Dig       Date:  2022-05       Impact factor: 2.086

Review 9.  Diagnostic methods and drug therapies in patients with ischemic colitis.

Authors:  YuShuang Xu; LiNa Xiong; YaNan Li; Xin Jiang; ZhiFan Xiong
Journal:  Int J Colorectal Dis       Date:  2020-09-16       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.